Skip to content

By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.

Silicon Valley GirlSilicon Valley Girl

How AI Is Breaking the Rules of Biology | Dr. Priscilla Chan, Chan Zuckerberg Initiative

In this episode of Silicon Valley Girl, Marina Mogilko sits down with Dr. Priscilla Chan, co-founder and co-CEO of the Chan Zuckerberg Initiative, to explore how AI is reshaping the future of medicine.

Dr. Priscilla ChanguestMarina Mogilkohost
Nov 6, 202530mWatch on YouTube ↗

Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.

At a glance

WHAT IT’S REALLY ABOUT

AI-built virtual cells aim to transform medicine and cure disease

  1. Priscilla Chan describes how a pivotal experience as a UCSF pediatrician—caring for children with conditions medicine couldn’t even name—pushed her toward funding basic science and tool-building through the Chan Zuckerberg Initiative (CZI) and its Biohubs.
  2. CZI’s core bet is that curing or preventing disease broadly won’t come from tackling one illness at a time, but from building platforms (datasets, wet-lab methods, and AI models) that make every scientist faster and more capable of testing risky ideas.
  3. She argues large language model-style approaches match biology’s “cell-by-gene” data structure, opening a near-term path toward virtual cells: computational models that simulate how human cells behave in health, disease, and in response to interventions.
  4. Chan forecasts major shifts in the next 5–10 years: more human-relevant experimentation in silico, earlier disease detection via continuous immune monitoring, and increasingly personalized therapies—especially through understanding and reprogramming the immune system.

IDEAS WORTH REMEMBERING

5 ideas

CZI’s strategy is platform-first, not disease-first.

Chan argues that building shared tools, datasets, and techniques makes the entire scientific ecosystem faster—enabling many diseases to be addressed in parallel rather than funding siloed, single-condition efforts.

LLM-like AI is well-suited to biological “cell-by-gene” data.

She describes a turning point when the team realized that large-model methods could extract meaning from the huge matrices produced by modern biology, accelerating interpretation and hypothesis generation.

Virtual cells could shift experimentation from animals to human-relevant simulations.

A core promise is cheaper, faster, more directly translatable testing on a computer model of human cell behavior—reducing reliance on mice/flies when translation to humans is weak.

The biggest patient impact is personalization—because nobody is “average.”

Chan emphasizes that today’s medicine often relies on population averages and best guesses; virtual-cell-style understanding could predict individual responses to drugs and conditions based on genetics and cellular context.

Immune-system modeling may unlock broad breakthroughs beyond infections.

She highlights autoimmune disease, neurodegeneration, and even cardiovascular plaque as areas where understanding immune balance and “tuning” immune behavior could produce major therapeutic gains.

WORDS WORTH SAVING

5 quotes

“Our mission is to cure, cure or prevent all disease.”

— Dr. Priscilla Chan

“Science is going to be fundamentally different in, like, five years.”

— Dr. Priscilla Chan

“Common diseases are rare diseases.”

— Dr. Priscilla Chan

“We don’t understand how labor is triggered… It’s magic.”

— Dr. Priscilla Chan

“It took us 10 years to map… around 100 million cells… [and] months to map a billion cells.”

— Dr. Priscilla Chan

Read the available transcript
Miscarriage openness and patient solidarityWhy CZI was created after becoming parentsMission: cure or prevent all diseaseTool-building vs single-disease philanthropySingle-cell atlases and scaling from millions to billionsVirtual cells: definition, feasibility timelinesVirtual immune system and real-time immune sensingPersonalized medicine and “common diseases as sub-diseases”AI + wet-lab flywheel (Cryo-ET, imaging, metadata)Physicians’ evolving role alongside AIRare As One: patient groups driving researchNear-term candidates: genetically well-understood diseases

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.